Criteria
Acute immune-mediated reactions
These occur within 24 hours of transfusion, and often during the transfusion itself.
Acute hemolytic transfusion reactions, depending on severity, may be characterized by:[3]
Pain along the infused extremity
Abdominal, chest, or back pain, which can accompany generalized symptoms
Hemoglobinuria, which can manifest as red urine
Progression to hypotension, renal failure, and disseminated intravascular coagulation (DIC) in severe cases
Positive direct antiglobulin test
Evidence of hemolysis upon visual inspection of the plasma.
Febrile nonhemolytic transfusion reactions are a diagnosis of exclusion. They are characteristically:
Associated with fever, specifically a rise in temperature of at least 1.8°F (1°C) above 98.6°F (37°C) for which no other cause is identifiable
Benign, although they initially may be indistinguishable from the onset of an acute hemolytic transfusion reaction
Not associated with evidence of hemolysis.
Allergic reactions are diagnosed clinically. They are characterized by:
Pruritus, flushing, and dyspnea
Symptoms within minutes of the initiation of transfusion
Urticaria that evolves; angioedema develops less commonly
Lack of evidence of hemolysis on lab tests
Anaphylaxis - a serious, potentially life-threatening, systemic allergic reaction - which may follow.[5] Anaphylaxis is generally rapid in onset, with variable signs and symptoms, and typically affects two or more body systems (e.g., cutaneous, respiratory, cardiovascular).[5] However, atypical presentations may only appear to affect a single system (e.g., isolated hypotension).[5] There may be features of respiratory compromise (e.g., dyspnea, wheezing, stridor, hypoxemia, reduced peak expiratory flow) and/or cardiovascular compromise or associated end-organ dysfunction (e.g., hypotension, hypotonia/collapse, syncope, incontinence).[5] Gastrointestinal symptoms may also be present (e.g., cramping abdominal pain, vomiting, diarrhea).[5] It should be noted that typical cutaneous features of anaphylaxis (e.g., urticaria, flushing, pruritus, angioedema) are not always present.[5] The diagnosis of anaphylaxis is clinical, based on the clinical history and the signs and symptoms present during the event.[5] In cases where anaphylaxis occurs, testing for anti-IgA levels and serum tryptase levels should be performed (without delaying emergency management) to aid with postacute confirmation of the diagnosis.[5][32] See Anaphylaxis (Diagnostic criteria).
Transfusion-related acute lung injury (TRALI) is characterized by:[38]
New onset of acute lung injury during or within 6 hours of transfusion of plasma-containing blood product(s)[7][8]
Absence of a temporal relationship to an alternative risk factor for acute lung injury (such as sepsis, aspiration pneumonitis, or pulmonary contusion)[8]
Acute lung injury
Criteria for acute lung injury, which include acute onset of symptoms, absence of circulatory overload, bilateral pulmonary infiltrates on chest x-ray, and hypoxemia as demonstrated by PaO2/FIO2 <300 mmHg.[8]
Delayed immune-mediated reactions
These usually occur days to weeks from the transfusion event.
Delayed hemolytic transfusion reactions are characterized by:[3]
Fever or anemia
Jaundice (in some patients)
Extravascular hemolysis (rarely causes acute renal failure or DIC)
Diagnosis supported by a new positive direct antiglobulin test and/or positive antibody screen, elevated LDH, and bilirubin.
Transfusion-associated graft-versus-host disease occurs 8 to 10 days after a transfusion and is characterized by:[9]
Maculopapular rash
Fever
Diarrhea
Bone marrow aplasia and rapid progress toward death in some patients
Occurrence in immunocompromised patients
Skin biopsy of the affected area, which is diagnostic.
Post-transfusion purpura are characterized by:
Bleeding from mucous membranes, gastrointestinal tract, and urinary tract
Associated thrombocytopenia, usually severe (less than 10 x 10⁹/L)[22]
Platelet antibody screen, which confirms diagnosis.
Use of this content is subject to our disclaimer